Women's Hormonal Health

PCOS, Periods & What Your Body Is Telling You

July 27, 2026 by

Kamal Elrasheed

Introduction

Millions of Nigerian women live with painful, irregular, or absent periods, and many are told this is normal or simply something they must endure. It is not always normal.

Your menstrual cycle is one of the most important signals your body sends about your overall health. When your cycle changes significantly, it may be a sign that something else is going on.

This guide explains one of the most common causes of hormonal imbalance Polycystic Ovary Syndrome (PCOS) and what every woman should know about her menstrual cycle.

What Is a Normal Period?

A normal menstrual cycle usually occurs every 21 to 35 days, with bleeding lasting 3 to 7 days.

Your menstrual flow should be manageable not so heavy that you soak through more than one pad every hour for several hours. Mild cramping is common, but severe pain that prevents you from carrying out your daily activities is not.

Signs That Need Medical Attention

Irregular periods: Cycles shorter than 21 days or longer than 35 days
Absent periods (amenorrhoea): No menstrual period for 3 months or more when not pregnant
Heavy periods (menorrhagia): Soaking through pads every hour, passing large clots, or bleeding for more than 7 days
Severely painful periods (dysmenorrhoea): Pain that stops you from working, attending school, or performing normal daily activities

Any of these symptoms deserve medical evaluation not silence.

What Is PCOS?

Polycystic Ovary Syndrome (PCOS) is the most common hormonal condition affecting women of reproductive age. It affects approximately 1 in 10 women worldwide, although it often goes undiagnosed, particularly in Northern Nigeria.

PCOS develops when the body produces higher-than-normal levels of androgens (hormones normally present in both men and women). These hormonal changes can interfere with regular ovulation and lead to a variety of symptoms.

Common Symptoms of PCOS

Irregular or absent periods
Difficulty becoming pregnant because ovulation is disrupted
Excess facial or body hair (hirsutism), especially on the chin, upper lip, chest, or abdomen
Acne that persists despite treatment, particularly around the jawline and chin
Weight gain or difficulty losing weight, especially around the abdomen
Thinning hair on the scalp
Darkened skin around the neck, armpits, or groin (acanthosis nigricans)
Fatigue, mood changes, and difficulty concentrating

PCOS and Fertility

PCOS is one of the leading causes of female infertility in Nigeria, but it is treatable.

Many women with PCOS are able to conceive with the right medical care. If you have been trying to become pregnant for 12 months without success and also have irregular periods or other symptoms of PCOS, speak with your doctor about being evaluated.

PCOS and Diabetes Risk

PCOS affects more than your menstrual cycle.

Women with PCOS have a significantly higher risk of developing Type 2 diabetes because many also have insulin resistance. Managing PCOS early can help improve both reproductive health and long-term metabolic health.

How Is PCOS Managed?

Although there is currently no cure for PCOS, its symptoms can usually be managed very effectively.

Lifestyle Changes

Healthy eating and regular physical activity help improve insulin resistance and hormone balance.

For women who are overweight, losing just 5–10% of body weight can improve menstrual regularity and increase the chances of ovulation.

Metformin

Metformin, a medicine commonly used for diabetes, may be prescribed to improve insulin resistance and help restore more regular menstrual cycles.

Available at Amkamed Pharmaceuticals with a valid prescription.

Hormonal Treatment

Combined oral contraceptive pills may be recommended for women who are not trying to become pregnant. They can:

Regulate menstrual cycles
Improve acne
Reduce excess hair growth
Help protect the lining of the uterus

Fertility Treatment

For women wishing to conceive, medicines that stimulate ovulation may be recommended.

Letrozole is now generally the preferred first-line medicine, while clomiphene remains an option in selected cases based on your doctor's assessment.

Inositol Supplements

Myo-inositol supplements may help improve insulin sensitivity and ovulation in some women. While research is encouraging, they should be considered as part of an overall treatment plan discussed with a healthcare professional rather than a replacement for medical care.

When Should You See a Doctor or Pharmacist?

Seek medical advice if:

Your periods are consistently irregular, absent, or extremely painful
You have been trying to conceive for more than 12 months without success
You have unexplained weight gain, excess facial hair, or severe acne together with irregular periods
You would like to better understand your hormonal health

Conclusion

Your menstrual cycle is one of your body's most important health signals.

Irregular or painful periods should not simply be accepted as "normal." They may be a sign of an underlying condition such as PCOS, which is common, often underdiagnosed, and highly manageable with the right care.

At Amkamed Pharmaceuticals in Gombe State, our pharmacists are available to provide trusted advice, discuss your concerns, and refer you to a qualified gynaecologist or endocrinologist when needed.

Concerned about irregular periods or symptoms of PCOS?

Visit Amkamed Pharmaceuticals, Gombe State, for professional advice, appropriate referrals, and compassionate care.

Amkamed Pharmaceuticals

amkamed.com

References

Diagnosis and Management of Heavy Menstrual Bleeding and Bleeding Disorders in Adolescents.JAMA Pediatrics. 2020. Borzutzky C, Jaffray J.Review

Gendering the Menstrual Cycle in Behavioral Neuroendocrinology.American Journal of Human Biology : The Official Journal of the Human Biology Council. 2026. Duchesne A, Jhajj KK, White N.RecentReview

Practice Bulletin No. 128: Diagnosis of Abnormal Uterine Bleeding in Reproductive-Aged Women.Obstetrics and Gynecology. 2012. Committee on Practice Bulletins—GynecologyGuideline

Menstrual bleeding, cycle length, and follicular and luteal phase lengths in women without known subfertility: A pooled analysis of three cohorts.Paediatric and Perinatal Epidemiology. 2020. Najmabadi S, Schliep KC, Simonsen SE, et al.

Polycystic Ovary Syndrome: Common Questions and Answers.American Family Physician. 2023. Williams T, Moore JB, Regehr J.Guideline

Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.The Journal of Clinical Endocrinology and Metabolism. 2023. Teede HJ, Tay CT, Laven JJE, et al.Guideline

Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.Fertility and Sterility. 2023. Teede HJ, Tay CT, Laven J, et al.Guideline

Prospective Risk of Type 2 Diabetes in 99 892 Nordic Women With Polycystic Ovary Syndrome and 446 055 Controls: National Cohort Study From Denmark, Finland, and Sweden.Human Reproduction. 2024. Glintborg D, Ollila MM, Møller JK, et al.

Polycystic Ovary Syndrome and Elevated Body Mass Index Independently Increase Type 2 Diabetes Risk With Obesity-Mediated Risk Dominating: A Real-World Data Analysis of US Patients.Fertility and Sterility. 2026. Sharafutdinov K, Hilpert J, Burghaus R, et al.Recent

Insulin resistance and β‐cell dysfunction and the relationship with cardio‐metabolic disorders among women with polycystic ovary syndrome.Clinical Endocrinology. 2018. Mu L, Zhao Y, Lai Y, Li R, Qiao J.

Diagnosis and Management of Infertility: A Review.The Journal of the American Medical Association. 2021. Carson SA, Kallen AN.Review

Letrozole Compared With Clomiphene Citrate for Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis.Obstetrics and Gynecology. 2023. Liu Z, Geng Y, Huang Y, et al.SR

Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome.The New England Journal of Medicine. 2014. Legro RS, Brzyski RG, Diamond MP, et al.RCT

Effects of Inositol in Women With Polycystic Ovary Syndrome: An Umbrella Review of Meta-Analyses From Randomized Controlled Trials.Frontiers in Endocrinology. 2025. Duan M, Yang M, Li C, et al.RecentSR